key: cord-0839305-hctrzqg2
authors: Zhao, Yi; He, Jingsong; Wang, Jiasheng; Li, Wei‐ming; Xu, Mi; Yu, Xu; Wu, Wei; Sun, Chunyin; Xu, Zherong; Zhang, Weifang; Hu, Yu; Huang, He
title: Development of Pancytopenia in a Patient with COVID‐19
date: 2020-09-29
journal: J Med Virol
DOI: 10.1002/jmv.26566
sha: ca28d077ed0fe319290d3cfe2778733af2b80df3
doc_id: 839305
cord_uid: hctrzqg2

The Coronavirus disease 2019 (COVID‐19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Laboratory findings of COVID‐19 include lymphopenia and elevated inflammatory markers. This article is protected by copyright. All rights reserved.

To the editor, The Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory findings of COVID-19 include lymphopenia and elevated inflammatory markers. However, pancytopenia is less common. Here, we reported a case of an elderly patient who developed pancytopenia with COVID-19.

A 69-year-old male presented to the emergency room in February 2020 with fever, dry cough, fatigue and dyspnea for 15 days. Patient has a history of right lung adenocarcinoma status post chemoradiation but has been in remission for two years. Of note, patient's wife was recently diagnosed with COVID-19. At the This article is protected by copyright. All rights reserved.

time of presentation, a complete blood count (CBC) panel showed white blood cell count (WBC) of 3.32x10 9 /L, hemoglobin of 87 g/L, and platelet of 206x10 9 /L, which were close to his baseline. Chest computed tomography (CT) without contrast showed ground-glass opacities of the right lower lobe. An oropharyngeal (OP) swab was performed and tested positive for SARS-CoV-2. Patient was admitted to the general medical floor and started on moxifloxacin and umifenovir.

One day later, the patient was transferred to the intensive care unit due to increasing oxygen requirement. Repeat laboratory work showed WBC 2.16x10 9 /L with neutrophil 0.39x10 9 /L and lymphocytes 0. In summary, we reported a case of pancytopenia associated with COVID-19 likely caused by bone marrow suppression.

Written consent for publication was obtained from the patient. YZ, JH and JW wrote the manuscript. W-ML, XM, XY, WW, SY, ZX, WZ, JC were involved in patient care. YH and HH supervised and revised the manuscript.

We declare no competing interests

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

This article is protected by copyright. All rights reserved.

Funding None